Developing as a significant breakthrough in the struggle against obesity, the drug is attracting considerable attention . This treatment combines properties of two established GLP-1 receptor agonists, semaglutide , with an unique glucose-dependent peptide component. Initial clinical data have indicated substantial body loss in patients with a h… Read More